RESEARCH CENTER GRANT PROGRAM GUIDELINES

NIH GUIDE, Volume 24, Number 33, September 22, 1995



P.T. 04



Keywords:

  Grants Administration/Policy+ 

  Drugs/Drug Abuse 



National Institute on Drug Abuse



PURPOSE



The National Institute on Drug Abuse (NIDA) provides support for

research center grants to provide a unique environment and to foster

a synergistic approach to research on drug abuse and addiction.  The

goal of the center grant program is to encourage the application of

multiple scientific perspectives and approaches to the problems of

drug abuse and addiction and to foster inter- and multi-disciplinary

collaboration and coordination.  Thematic integration is another

defining feature of center grants.  They are intended to serve as an

enabling mechanism for the conduct of innovative, state-of-the-art

research on drug abuse and addiction that could not or would not be

conducted without the center.  A NIDA research center should embody

the concept that the "whole is greater than the sum of its parts."



NIDA research centers are expected to serve as regional or national

research resources.  They are expected to attract both established

and promising investigators into drug abuse research and provide

opportunities for research training, career development, and

mentoring.



Through its centers program, NIDA seeks to encourage outstanding

scientists to bring a full range of expertise, approaches, and

advanced technologies to the study of problems related to drug abuse

and addiction.  NIDA research centers are broadly based investigative

endeavors, encompassing or supporting research in a variety of areas

including:  biological, biomedical, behavioral, and clinical

sciences, neuroscience, prevention, and services research.



These guidelines summarize the purpose and intent of the NIDA

research center grant program including:  (I) eligibility, (II)

mechanisms of support, (III) period of support, (IV) organizational,

administrative, and budgetary elements of NIDA research centers, (V)

application procedures, (VI) submission dates, (VII) procedures for

review of competing and non-competing applications, (VIII) transition

policy for existing NIDA centers, and (IX) other considerations.



Center grant applications may be submitted on an ongoing basis in any

of the scientific areas supported by the NIDA and do not require a

specific program announcement or Request for Applications (RFA) to be

considered.  However, from time to time, NIDA may issue program

announcements or RFAs to specifically solicit center grant

applications that may have unique and specific requirements that go

beyond these general program guidelines.  Applicants are strongly

encouraged to consult with appropriate NIDA staff to become familiar

with these additional, program-specific requirements.



INQUIRIES



With the issuance of these guidelines, NIDA will no longer accept

applications in response to Program Announcement PA-92-04, Drug Abuse

Prevention Centers, published in the NIH Guide, September 27, 1991

and will no longer accept P50 grants in response to PA-91-33,

Vulnerability to Drug Abuse Research, Vol. 20. No. 11, March 15,

1991.



The Research Center Grant Program Guidelines are available on NIDA's

Home Page (http://www.nida.nih.gov/) and may be obtained from:



Grants Management Branch

National Institute on Drug Abuse

Parklawn Building, Room 8A-54

5600 Fishers Lane

Rockville, MD  20857

Telephone:  (301) 443-6710



.

Return to 1995 Index

Return to NIH Guide Main Index

	Office of Extramural Research (OER)			National Institutes of Health (NIH) 9000 Rockville Pike Bethesda, Maryland 20892			Department of Health and Human Services (HHS)
Note: For help accessing PDF, RTF, MS Word, Excel, PowerPoint, Audio or Video files, see Help Downloading Files.